Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Listen to George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer audience questions from a series of live CCO Webinars focused on when and how to test for NTRK fusions in solid tumors and best practices in using TRK inhibitors.

George D. Demetri, MD
Program Director Alexander Drilon, MD Pashtoon M. Kasi, MD, MS Released: August 14, 2020